Innovation News Network brings you the latest research and innovation news from the fields of science, environment, energy, critical raw materials, technology, and electric vehicles.
UBC boosts nuclear fusion reaction using bench-top reactor
UBC researchers have boosted nuclear fusion reaction rates using a small bench-top reactor, opening a new pathway for fusion research.
UK Industrial Strategy set to boost science and tech projects in Northern Ireland
Science and technology projects in Northern Ireland are set to be boosted by at least £30m from the UK Industrial Strategy.
New NHS bladder cancer treatment doubles survival rates
A new NHS-approved bladder cancer treatment doubles survival rates and offers fresh hope for patients with advanced disease.
Tackling deforestation with Earth observation technologies
Earth observation technologies are vital in the fight against deforestation, providing essential insights into forest health and changes.
New US gamma-ray detector promises breakthroughs in understanding atomic nuclei
GRETA detector is set to revolutionise nuclear physics by providing unprecedented insights into the structure and behaviour of atomic nuclei.
How low-carbon fuels decarbonise heavy transport
The transition to low-carbon fuels offers a viable solution to curbing greenhouse gases caused by heavy transport. Find out more here.
AquAffirm’s smartphone-enabled water quality sensors offer ‘ripple of hope’ for PFAS detection
AquAffirm’s smartphone-powered tech is revolutionising PFAS monitoring – bringing lab-grade testing to the field, and to the world.
The power of plasma propulsion: A new era in space travel
Learn how plasma propulsion offers a more efficient and sustainable alternative to chemical rockets for deeper space exploration.
Exploring the importance of helium recycling
Learn about how helium recycling offers a sustainable solution to preserve this finite resource, ensuring its long-term availability.
BioNxt Solutions fast-tracks US patent for drug delivery platform
BioNxt marks two key milestones in the expansion of its proprietary drug delivery platform targeting neurological autoimmune disorders.